Lumasiran
ATC A16AX18 · 6 markets · 8 records
AU 3 records · 3 strengths
- 94.5 mg/0.5 mLinjectionOXLUMO
- 100 mginjectionOXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
Records without a stated strength · 1 OXLUMO
US 1 records · 1 strengths
- 94.5 mg/0.5 mLinjectionOXLUMO
GB 1 records · 1 strengths
- 94.5 mg/0.5 mLinjectionOxlumo 94.5mg/0.5ml solution for injection vials
CA 1 records · 1 strengths
- 94.5 mgliquidOXLUMO
ES 1 records · 1 strengths
- 189 mg/1 mLinjectionOXLUMO
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 OXLUMO
| Strength / form / release | US | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|---|
| 94.5 mg/0.5 mL injection | OXLUMO | Oxlumo 94.5mg/0.5ml solution for injection vials | OXLUMO | |||
| 94.5 mg liquid | OXLUMO | |||||
| 189 mg/1 mL injection | OXLUMO | |||||
| 100 mg injection | OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial. | |||||
unknown | OXLUMO | OXLUMO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in ES and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en ES que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 ES 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 ES 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.